Opening the Door to Next-Generation LDL-C Lowering Agents
In the early 2000s, researchers uncovered a unique genetic clue in people with a reduced risk of heart disease: specific mutations in the PCSK9 gene associated with lower levels of…
From Breakthrough Science to Real-World Impact: Amgen’s Legacy in Cardiovascular Disease Care
